Journal of Medicinal Chemistry · 2014 · 109 citations · 38 references
MedicineOncologyPharmacologyApoptosisCancer PharmacologyChemotherapyCytotoxic ChemotherapyDna CrosslinkingChronic Lymphocytic Leukemia TherapyCytotoxicity AssaysDna Cross-linkingDna Crosslinking CytotoxicityLymphoma ChemotherapyNitrogen MustardsReactive Oxygen Species Generation
Reducing host toxicity is one of the main challenges of cancer chemotherapy. Many tumor cells contain high levels of ROS that make them distinctively different from normal cells. We report a series of ROS-activated aromatic nitrogen mustards that selectively kill chronic lymphocytic leukemia (CLL) over normal lymphocytes. These agents showed powerful DNA cross-linking abilities when coupled with H2O2, one of the most common ROS in cancer cells, whereas little DNA cross-linking was detected without H2O2. Consistent with chemistry observation, in vitro cytotoxicity assay demonstrated that these agents induced 40-80% apoptosis in primary leukemic lymphocytes isolated from CLL patients but less than 25% cell death to normal lymphocytes from healthy donors. The IC50 for the most potent compound (2) was ~5 μM in CLL cells, while the IC50 was not achieved in normal lymphocytes. Collectively, these data provide utility and selectivity of these agents that will inspire further and effective applications.
38
Production of large amounts of hydrogen peroxide by human tumor cells.
Ted P. Szatrowski, Carl Nathan · PubMed · 1991 · 2.5K citations
Selective killing of cancer cells by a small molecule targeting the stress response to ROS
Lakshmi Raj, Takao Ide, Aditi U. Gurkar et al. · Nature · 2011 · 1K citations
Medicine, Cancer Biology, Oncology +15
Superoxide dismutase as a target for the selective killing of cancer cells
Peng Huang, Feng Li, Eli Oldham et al. · Nature · 2000 · 841 citations